Liposome-based intracellular kinetics of doxorubicin in K562/DOX cells

Pharmazie

Volumn 63, Issue 9, 2008, Pages 646-649

  Xu, Dong Hang ^a,b   Gao, Jian Qing ^a   Liang, Wen Quan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; LIPOSOME;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

ANTIBIOTICS, ANTINEOPLASTIC; CELL NUCLEUS; CYTOPLASM; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; K562 CELLS; LIPOSOMES;

EID: 52649131934     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8082     Document Type: Article

References (20)

1. Amselem S, Gabizon A, Barenholz Y (1990) Optimization and upscaling of doxorubicin-containing liposomes for clinical use. J Pharm Sci 79: 1045-1052.
2. Bender RA, Zwelling LA, Doroshow JH, Locker GY, Hande KR, Murison DS, Cohen M, Myers CE, Chabner BA (1978) Antineoplastic drugs: clinical Pharmacology and therapeutic use. Drugs 16: 46-87.
3. Beyer U, Rothern-Rutishauser B, Unger C, Wunderli-Allenspach H, Kratz F (2001) Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy. Pharm Res 18: 29-38.
4. Croce AC, Bottiroli G, Supino R, Favini E, Zuco V, Zunino F (2004) Subcellular localization of the camptothecin analogues, topotecan and gimatecan. Biochem Pharmacol 67: 1035-1045.
5. Gabr A, Kuin A, Aalders M, El-Gawly H, Smets LA (1997) Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH. Cancer Res 57: 4811-4816.
6. Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A (2000) Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res 6: 1949-1957.
7. Kobayashi T, Ishida T, Okada Y, Ise S, Harashima H, Kiwada H (2007) Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells. Int J Pharm 329: 94-102.
8. Lahiri DK, Ge YW (2000) Electrophoretic mobility shift assay for the detection of specific DNA-protein complex in nuclear extracts from the cultured cells and frozen autopsy human brain tissue. Brain Res Protoc 5: 257-265.
9. Leonessa F, Clarke R (2003) ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer 10: 43-73.
10. Lundberg BB, Risovic V, Ramaswamy M, Wasan KM (2003) A lipophilic paclitaxel derivativem corporated in a lipid emulsion for parenteral administration J Control Release 86: 93-100.
11. Nobili S, Landini I, Giglioni B, Mini E (2006) Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets 7: 861-879.
12. Pakunlu RI, Wang Y, Saad M, Khandare JJ, Starovoytov V, Minko T (2006) In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. J Control Release 114: 153-162.
13. Praet M, Stryckmans P, Ruysschaert JM (1996) Cellular uptake, cytotoxicity, and transport kinetics of anthracyclines in human sensitive and multidrug-resistant K562 cells. Biochem Pharmacol 51: 1341-8.
14. Pratesi G, Beretta GL, Zunino F (2004) Gimatecan, a novel camptothecin with a promising preclinical profile. Anticancer Drugs 15: 545-552.
15. Shabbits JA, Mayer LD (2003) Intracellular delivery of ceramide lipids via liposomes enhances apoptosis in vitro. Biochim Biophys Acta 1612: 98-106.
16. Spector DL, Goldman RD, Leinwand LA (1998) Culture and in vitro differentiation of mouse embryonic stem cells. In Cells: Culture and Biochemical Analysis of Cells, A Laboratory Manual Vol. 1, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA.
17. Thierry AR, Vigé D, Coughlin SS, Belli JA, Dritschilo A, Rahman A (1993) Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes. FASEB J 7: 572-579.
18. van Ark-Otte J, Kedde MA, van der Vijgh WJ, Dingemans AM, Jansen WJ, Pinedo HM, Boven E, Giaccone G (1998) Determinants of CPT-11 and SN-38 activities in human lungcancer cells. Br J Cancer 77: 2171-2176.
19. Xiong XB, Huang Y, Lu WL, Zhang X, Zhang H, Nagai T, Zhang Q (2005) Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J Control Release 107: 262-275.
20. Zhao YX, Gao JQ, Qiao HL, Chen HL, Liang WQ (2006) Development and validation of asensitive reversed-phase HPLC method to determine intracellular accumulation of hydroxycamptothecin. J Pharm Biomed Anal 41: 1007-1010.